Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oncogenic signaling

C L Jones1, M A Kane

  • 1Denver Veterans Affairs Medical Center, CO 80220, USA.

Current Opinion in Oncology
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Cancer arises from uncontrolled cell growth due to mutations in cell division genes. Understanding oncogenes and tumor-suppressor genes reveals how these genetic alterations drive cancer progression and offers clinical insights.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo-Controlled, Biomarker-Enriched Trial in Patients With the SOD2 Ala/Ala Variant.

The Prostate·2025
Same author

Military Anaesthesia in contingencies: what skill sets are required and how will we prepare our trainees?

Journal of the Royal Army Medical Corps·2017
Same author

Splice site mutation in factor X gene manifesting as severe intracranial haemorrhage in neonatal period with a challenging treatment course.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Algorithm for the treatment of status epilepticus: an Australian perspective.

Internal medicine journal·2016
Same author

The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.

Vaccine·2013
Same author

Efficacies of spinosad and a combination of chlorpyrifos-methyl and deltamethrin against phosphine-resistant Rhyzopertha dominica (Coleoptera: Bostrichidae) and Tribolium castaneum (Coleoptera: Tenebrionidae) on wheat.

Journal of economic entomology·2013
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Cancer is characterized by uncontrolled cell proliferation, stemming from disruptions in normal cell division.
  • Genetic alterations, including germline or somatic mutations, are fundamental to cancer development.

Purpose of the Study:

  • To provide an overview of cellular signaling pathways involved in cancer.
  • To explain how these pathways are altered in cancerous cells.
  • To discuss the clinical implications of aberrant oncogene and tumor-suppressor gene expression.

Main Methods:

  • Review of existing literature on cell cycle regulation, oncogenes, and tumor-suppressor genes.
  • Analysis of cellular signaling pathways implicated in cancer.
  • Examination of clinical data related to gene expression in cancer patients.

Related Experiment Videos

Main Results:

  • Oncogenes (viral genes inducing cell transformation) and tumor-suppressor genes (cell cycle regulators) play critical roles.
  • Mutations or deletions in tumor-suppressor genes release cell cycle control, promoting proliferation.
  • Altered signaling pathways and abnormal gene expression have significant clinical relevance.

Conclusions:

  • Understanding the molecular basis of cancer, particularly the roles of oncogenes and tumor-suppressor genes, is crucial.
  • Aberrant cellular signaling and genetic mutations drive tumorigenesis.
  • Knowledge of these mechanisms informs clinical strategies for cancer treatment and management.